NASUS PHARMA LTD. (NSRX) Total liabilities
NASUS PHARMA LTD. (NSRX) total liabilities at each fiscal year-end, per SEC filings.
$2.2MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NSRX financial trends
NSRX RevenueNSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating incomeNSRX Operating marginNSRX Operating cash flowNSRX Free cash flowNSRX Capital expendituresNSRX Return on equityNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Shareholders’ equityNSRX overview →